This information has been reviewed and approved by Thomas Ylioja, MSW, PhD (May 2024)
Such instances would apply to section 505(b)(2) drug products, drugs that were previously multiple source drugs where all other drugs under the same billing and payment code were discontinued (applicable only if the sole remaining product was not approved under an ANDA), and to any other situations where a drug was previously in a grouped billing and payment code (other than a NOC code)
Every stick arrives fresh, intact, and often better than cigars Ive picked up in person from brick-and-mortar shops
1 Infectious rhinitis is possibly the most common type of rhinitis
Specifically, we are proposing to revise 414.507(d) to indicate that for CY 2024, payment may not be reduced by more than 0.0 percent as compared to the amount established for CY 2023, and for CYs 2025 through 2027, payment may not be reduced by more than 15 percent as compared to the amount established for the preceding year